These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35893244)

  • 41. NMR-based metabolomics: from sample preparation to applications in nutrition research.
    Brennan L
    Prog Nucl Magn Reson Spectrosc; 2014 Nov; 83():42-9. PubMed ID: 25456316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and Perspectives.
    Letertre MPM; Giraudeau P; de Tullio P
    Front Mol Biosci; 2021; 8():698337. PubMed ID: 34616770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overview of NMR Spectroscopy-Based Metabolomics: Opportunities and Challenges.
    Nagana Gowda GA; Raftery D
    Methods Mol Biol; 2019; 2037():3-14. PubMed ID: 31463836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.
    Rankin NJ; Preiss D; Welsh P; Burgess KE; Nelson SM; Lawlor DA; Sattar N
    Atherosclerosis; 2014 Nov; 237(1):287-300. PubMed ID: 25299963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.
    Dunn WB; Broadhurst DI; Atherton HJ; Goodacre R; Griffin JL
    Chem Soc Rev; 2011 Jan; 40(1):387-426. PubMed ID: 20717559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NMR metabolomics: A look ahead.
    Wishart DS
    J Magn Reson; 2019 Sep; 306():155-161. PubMed ID: 31377153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quo Vadis
    Salzer L; Witting M
    Metabolites; 2021 Apr; 11(5):. PubMed ID: 33947148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-Resolution Liquid Chromatography-Mass Spectrometry-Based Metabolomic Discrimination of
    Tsujimoto T; Yoshitomi T; Maruyama T; Yamamoto Y; Hakamatsuka T; Uchiyama N
    J Nat Prod; 2019 Aug; 82(8):2116-2123. PubMed ID: 31322883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolite quantification by NMR and LC-MS/MS reveals differences between unstimulated, stimulated, and pure parotid saliva.
    Figueira J; Gouveia-Figueira S; Öhman C; Lif Holgerson P; Nording ML; Öhman A
    J Pharm Biomed Anal; 2017 Jun; 140():295-300. PubMed ID: 28380387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New findings on urinary prostate cancer metabolome through combined GC-MS and
    Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
    Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-Platform Comparison of Amino Acid Metabolic Profiling in Three Model Organisms Used in Environmental Metabolomics.
    D'eon JC; Lankadurai BP; Simpson AJ; Reiner EJ; Poirier DG; Vanlerberghe GC; Simpson MJ
    Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review.
    Demicheva E; Dordiuk V; Polanco Espino F; Ushenin K; Aboushanab S; Shevyrin V; Buhler A; Mukhlynina E; Solovyova O; Danilova I; Kovaleva E
    Metabolites; 2024 Jan; 14(1):. PubMed ID: 38248857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in Plant Metabolomics and Its Applications in Stress and Single-Cell Biology.
    Katam R; Lin C; Grant K; Katam CS; Chen S
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of metabolomics to preeclampsia diagnosis.
    Nobakht M Gh BF
    Syst Biol Reprod Med; 2018 Oct; 64(5):324-339. PubMed ID: 29965778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of compatibility between extraction methods for NMR- and LC/MS-based metabolomics.
    Beltran A; Suarez M; Rodríguez MA; Vinaixa M; Samino S; Arola L; Correig X; Yanes O
    Anal Chem; 2012 Jul; 84(14):5838-44. PubMed ID: 22697410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analytical Platforms for Mass Spectrometry-Based Metabolomics of Polar and Ionizable Metabolites.
    Macedo AN; Faccio AT; Fukuji TS; Canuto GAB; Tavares MFM
    Adv Exp Med Biol; 2021; 1336():215-242. PubMed ID: 34628634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer.
    Almalki AH
    Metabolites; 2023 Sep; 13(10):. PubMed ID: 37887362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integration of GC-MS and LC-MS for untargeted metabolomics profiling.
    Zeki ÖC; Eylem CC; Reçber T; Kır S; Nemutlu E
    J Pharm Biomed Anal; 2020 Oct; 190():113509. PubMed ID: 32814263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolomics: A Way Forward for Crop Improvement.
    Razzaq A; Sadia B; Raza A; Khalid Hameed M; Saleem F
    Metabolites; 2019 Dec; 9(12):. PubMed ID: 31847393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.